Relationship between anti-epileptic drug use and SUDEP risk

Takeaway

  • Antiepileptic drugs (AEDs) used in monotherapy or polytherapy do not pose an increased risk for sudden unexpected death in epilepsy (SUDEP), but polytherapy – particularly with lamotrigine, valproic acid, and levetiracetam – or monotherapy with levetiracetam, was associated with reduced risk of SUDEP. Statins may also be protective for SUDEP.

Why this matters ?

    While there is an urgent need to reduce the risk of SUDEP, data on the contribution of AEDs are limited. Understanding the relationship between AEDs and SUDEP risk may improve clinical outcomes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.